CAS: 2571-54-2; 2,4,6-Trimethoxybenzonitrile

上下游产品

2,4,6-trimethoxybenzaldehyde 1,2,3-trimethoxybenzene potassium cyanide 2,4,6-trimethoxybenzaldehyde oxime 2,4,6-trimethoxybenzylamine 2,4,6-trimethoxybenzonitrile N-oxide N-Trifluoracetyl-glycin-(2,4,6-Trimethoxy-benzylamid) N-(p-Methoxy-benzyloxycarbonyl)-glycin-(2,4,6-Trimethoxy-benzylamid)

📜2,4,6-三甲氧基苯甲醛置于xy-Zeolite,盐酸羟胺体系中,化学反应 0.02H,以90%的收率获得2,4,6-三甲氧基苯甲腈
参考文献:使用 Hy 沸石将醛非常方便和高效地一锅法转化为腈类和酮类转化为酰胺
标题:使用 Hy 沸石将醛非常方便和高效地一锅法转化为腈类和酮类转化为酰胺
摘要:使用 Hy-沸石作为催化剂,醛类转化为腈类和酮类转化为酰胺类可以方便有效地进行一锅法转化.研发了微波辐射和常规方法.
Doi:10.1055/s-2002-22701

专利信息

专利号:US-6933303-B2
优先权日:2001-10-19
标 题:Heteroaryl-fused nitrogen heterocycles as therapeutic agents
发明人：MJALLI ADNAN M M; ANDREWS ROBERT C; XIE RONGYUAN; YARRAGUNTA RAVINDRA R; REN TAN
权利人:TRANSTECH PHARMA INC
摘要:This invention provides compounds which are useful as inhibitors of protein tyrosine phosphatases (PTPases). As inhibitors of PTPases, the compounds of the invention are useful for the management, treatment, control and adjunct treatment of diseases mediated by PTPase activity. Such diseases include type I diabetes, type II diabetes, immune dysfunction, AIDS, autoimmunity, glucose intolerance, obesity, cancer, psoriasis, allergic diseases, infectious diseases, inflammatory diseases, diseases involving the modulated synthesis of growth hormone or the modulated synthesis of growth factors or cytokines which affect the production of growth hormone, or Alzheimer's disease.

专利号:US-7569606-B2
优先权日:2006-01-26
标 题 :Platinum complexes with mononitrile-containing ligands
发明人：XIAO ZEJUN; HAUSHEER FREDERICK H; PETLURU PAVANKUMAR
权利人:BIONUMERIK PHARMACEUTICALS INC
摘要:Disclosed herein are novel platinum-based complexes possessing one nitrile substituent group (mononitrile) covalently-bonded to the platinum, one or more nitrogen donor ligands capable of forming hydrogen bonds with the bases in DNA or RNA and leaving groups (i.e., L 1 and L 2 )which can be hydrolyzed iii vivo to active species, which can then form coordinate adducts with DNA or RNA at the Guanine or Adenine bases thereof. Also disclosed herein are the reaction schemes for the synthesis of said platinum complexes, as well as methods of treatment of various types of cancer by the administration of a pharmaceutically-effective dose of said novel platinum complexes.